By Conjoint Professor David goldstein

Conference Papers

Xu ZH; Vonlaufen A; Yang L; Phillips PA; Fiala-Beer E; Biankin AV; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2008, 'Pancreatic stellate cells stimulate angiogenesis in pancreatic cancer and accompany pancreatic cancer cells to distant metastatic sites', in Pancreas, Lippincott Williams & Wilkins, Philadelphia, PA, USA, pp. 502 - 503, presented at Pancreas

Moore M; Ding K; Parulekar W; Kotecha J; Whitehead M; Goldstein D; Hamm J; Das-Gupta A, 2007, 'Erlotinib improves clinical outcomes when added to gemcitabine in pancreatic cancer; prolonged survival among patients with metastatic disease. An exploratory sub-analysis of the NCIC.CTG study PA.3', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, SPAIN, Barcelona, pp. VII14 - VII14, presented at 9th World Congress on Gastrointestinal Cancer, SPAIN, Barcelona, 28 June 2007 - 01 July 2007

Wilcken NR; Goldstein D; Nowak AK; Beale PJ; Jefford M; Dhillon H; O'Connell R; Heritier S; Simes RJ; Stockler M, 2007, 'A placebo-controlled trial of Sertraline's effects on symptoms, well-being and survival in advanced cancer: The ZEST Trial', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY

Goldstein D; Shannon J; Brown C; Tebbutt N; Ackland S; Van Hazel G; Abdi E; Jefford M; Gainford MC; Adams K, 2007, 'ABC; An AGITG trial of fixed dose rate (FDR) gemcitabine (gem) and cisplatin for patients (pts) with advanced biliary tract cancer (ABC)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000455043703565&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Leighl NB; Shepherd H; Butow P; Clarke SJ; McJannett M; Beale P; Wilcken N; Moore MJ; Chen EX; Tattersall MH; Goldstein D, 2007, 'When the goal is not cure: A randomized trial of a patient decision aid in advanced colorectal cancer', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000455043701477&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Shepherd L; Goldstein D; Thewes B; Whitford H; Brummell V, 2006, 'Pilot study of a clinical psychology service via videoconferencing for rural cancer patients in Australia', in PSYCHO-ONCOLOGY, WILEY-BLACKWELL, pp. S457 - S457, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000242413901519&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Underhill CR; Goldstein D; Gorbunova VA; Biakhov MY; Bazin IS; Melemed A; Hossain A; Granov DA, 2006, 'A randomized phase II trial of pemetrexed plus irinotecan (ALIRI) versus leucovorin-modulated 5-FU plus irinotecan (FOLFIRI) in first-line treatment of locally advanced or metastatic colorectal cancer', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, TURKEY, Istanbul, pp. 118 - 118, presented at 31st Congress of the European-Society-for-Medical-Oncology, TURKEY, Istanbul, 29 September 2006 - 03 October 2006, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000248078900349&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Spry N; Harvey J; MacLeod C; Borg M; Ngan S; Millar J; Graham P; Delaney G; Reece W; Goldstein D, 2006, 'Concurrent infusional 5-fluorouracil and 'protocol specific' 3D conformal radiotherapy is effective and safe in combination with 'sandwich' gemcitabine in the management of locally advanced pancreatic cancer', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, SPAIN, Barcelona, pp. 21 - 21, presented at Satellite Symposium on New Horizons for Gastric Cancer held in conjunction with the 8th World Congress on Gastrointestinal Cancer, SPAIN, Barcelona, 29 June 2006, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239782000009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tebbutt N; Gebski V; Strickland A; Gibbs D; Walpole E; Ganju V; Goldstein D; Munro S; Harrod M; Van Hazel G, 2006, 'Randomised phase II study evaluating weekly docetaxel in combination with cisplatin and 5FU or capecitabine in metastatic oesophago-gastric cancer.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, GA, Atlanta, pp. 194S - 194S, presented at 42nd Annual Meeting of the American-Society-of-Clinical-Oncology, GA, Atlanta, 02 June 2006 - 06 June 2006

Stockler MR; Heritier S; Nowak AK; Goldstein D; Turner J; Jeord M; Glasgow A; Abdi E; Beale PJ; Carter C, 2006, 'The time taken to complete quality of life questionnaires in an advanced cancer trial.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, GA, Atlanta, pp. 491S - 491S, presented at 42nd Annual Meeting of the American-Society-of-Clinical-Oncology, GA, Atlanta, 02 June 2006 - 06 June 2006

Joshi SB; Vonlaufen A; Xu Z; Daniel B; Qu CF; Kumar RK; Pirola RC; Wilson JS; Goldstein D; Apte MV, 2006, 'Pancreatic stellate cells stimulate pancreatic cancer growth and metastasis: Findings of a novel orthotopic model of pancreatic cancer', in Pancreas, Lippincott Williams & Wilkins, Philadelphia, PA, USA, -

Joshi SB; Qu CF; Phillips PA; Pirola RC; Wilson JS; Goldstein D; Apte MV, 2005, 'Epithelial-stromal interactions in pancreatic cancer: do pancreatic cancer cells actively recruit host stromal cells for their own benefit?', in The Peter McCallum Institute (ed.), 6th Peter MacCallum Cancer Symposium, Molecular and Cell Biology of Cancer, Melbourne, pp. 21 - 21, presented at 6th Peter MacCallum Cancer Symposium, Molecular and Cell Biology of Cancer, Melbourne, 14 November 2005 - 16 November 2005

Au HJ; Goldstein D; Ding K; Parulekar W; Gallinger S; Moore M, 2005, 'DOES EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR (EGFRI) SKIN TOXICITY AFFECT QOL? RESULTS FROM A NATIONAL CANCER INSTITUTE OF CANADA CLINICAL TRIALS GROUP (NCIC-CTG) RCT', in QUALITY OF LIFE RESEARCH, SPRINGER, pp. 2135 - 2135, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000520235700429&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Goldstein D; Spry N; Van Hazel GA; Underhill CR; Kotasek D; Harvey JE; Links MJ; Shapiro J; Iacopetta BJ, 2005, 'Combined modality therapy for pancreatic carcinoma: An australian pancreatic cancer group study of the addition of gemcitabine (G) to concurrent infusional 5-fluorouracil (CI5FI)and 3D conformal radiotherapy (RT)-final outcomesAbstract No: 4101', in Bhave AB (ed.), Journal of Clinical Oncology, Jitendar P Vij, Jaypee Brothers Medical Publishers (P) Ltd, New Delhi, India, pp. 203s - 203s, presented at 42nd Annual Meeting of the Amercian Society of Clinical Oncology, Atlanta, Georgia USA, 02 June 2005 - 06 June 2005

Mitchell P; Goldstein D; Michael M; Beale P; Friedlander M; Zalcberg J; Clarke S; White S, 2005, 'Addition of gabapentin (G) to a modified FOLFOX regimen does not reduce neurotoxicity in patients (pts) with advanced colorectal cancer (CRC).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, FL, Orlando, pp. 266S - 266S, presented at 41st Annual Meeting of the American-Society-of-Clinical-Oncology, FL, Orlando, 13 May 2005 - 17 May 2005, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000230326601475&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Moore MJ; Goldstein D; Hamm J; Figer A; Hecht J; Gallinger S; Au H; Ding K; Christy-Bittel J; Parulekar W, 2005, 'Erlotinib plus gemcitabine compared to gemcitabine alone in patients with advanced pancreatic cancer. A phase III trial of the National Cancer Institute of Canada Clinical Trials Group [NCIC-CTG].', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, FL, Orlando, pp. 1S - 1S, presented at 41st Annual Meeting of the American-Society-of-Clinical-Oncology, FL, Orlando, 13 May 2005 - 17 May 2005

Goldstein D; van Hazel G; Pavlakis N; Olver I, 2005, 'Selective internal radiation therapy (SIRT) plus systemic chemotherapy with irinotecan. A phase I dose escalation study', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, FL, Orlando, pp. 296S - 296S, presented at 41st Annual Meeting of the American-Society-of-Clinical-Oncology, FL, Orlando, 13 May 2005 - 17 May 2005

Goldstein D; Van Hazel GA; Underhill CR; Kotasek D; Harvey JE; Links MR; Shapiro J; Iacopetta BJ; Spry N; Lilly E, 2004, '', in Journal of Clinical Oncology, Jitendar P Vij, Jaypee Brothers Medical Publishers (P) Ltd, New Delhi, India

Evans VE; Vockler C; Magnay J; Friedlander N; Lewis CR; Goldstein D; Walsh BR; Holden BA; Willcox MD, 2000, 'Lacryglobin in human tears, a potential marker for cancer metastasis', in Australian and New Zealand Journal of Ophthalmology, Blackwell Science Asia, South Carlton, Australia, pp. 36 - 36, presented at Australasian Ophthalmic and Visual Sciences Meeting 2000, Sydney

Bishop JF; Dewar J; Toner G; Tattersall MH; Olver I; Ackland S; Kennedy I; Goldstein D; Gurney H; Walpole E; Levi J; Stephenson J, 1997, 'A randomized study of paclitaxel versus cyclophosphamide/methotrexate/- fluorouracil/prednisone in previously untreated patients with advanced breast cancer: Preliminary results', in Seminars in Oncology, pp. S17 - S17

Newell M; Milliken S; Chipman M; Cebon J; Lewis C; Goldstein D; Cooper DA, 1997, 'DOX-SL (stealth liposomal doxorubicin HCL) maintenance therapy after response in AIDS-related Kaposi's sarcoma', in JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, LIPPINCOTT-RAVEN PUBL, pp. 15 - 15, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WU25100049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Padiglione AA; Goldstein D; Law MG; Kaldor JM; Mijch AM; Hoy JF, 1997, 'Prognosis in Kaposi's sarcoma as an initial and later AIDS associated illness', in JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, LIPPINCOTT-RAVEN PUBL, pp. 16 - 16, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WU25100051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Goldstein D; Milliken ST; Chipman M; Lebon J; Lewis CR; Cooper DA, 1997, 'Dox-SL maintenance therapy after response in AIDS-related Kaposis Sarcoma.', in J. AIDS and Human Retrovirology, presented at J. AIDS and Human Retrovirology

Goldstein D; Davis A; Milliken ST, 1997, 'Long term follow-up of CEOP in the treatment of HIV related NHL.', in J. AIDS and Human Retrovirology, presented at J. AIDS and Human Retrovirology

Goldstein D; Padigliene A; Law MG; Kaldor JM; Mijch AM; Hoy JF, 1997, 'Prognosis of Kaposi`s sarcoma as an initial and later AIDS associated illness.', in J. AIDS and Human Retrovirology, presented at J. AIDS and Human Retrovirology

Newell M; Milliken S; Chipman M; Cebon J; Lewis C; Goldstein D; Cooper DA, 1996, 'DOX-SL (stealth liposomal doxorubicin HCl) maintenance therapy after response in AIDS-related Kaposi's sarcoma.', in AIDS, LIPPINCOTT WILLIAMS & WILKINS, pp. P133 - P133, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996VU96300195&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Goldstein D; Cooper DA, 1993, 'Current status of clinical trials in HIV disease in Australia', in Journal of Acquired Immune Deficiency Syndromes, pp. S68 - S71

GOLDSTEIN D; SIELAFF K; STORER BE; WITT PL; BROWN RR; DATTA SP; SMALLEY RV; BORDEN EC, 1989, 'EFFECT OF DOSE ON BIOLOGICAL RESPONSE MODIFICATION BY INTERFERON-BETA-SER', in JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, LIPPINCOTT-RAVEN PUBL, pp. 327 - 328

WITT PL; GOLDSTEIN D; CORMIER E; BORDEN EC, 1989, 'EFFECTS OF INTERFERON AND ESTROGEN ON THE CYTOSKELETON OF HUMAN-BREAST TUMOR-CELL LINES', in JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, LIPPINCOTT-RAVEN PUBL, pp. 322 - 322

GOLDSTEIN D; SIELAFF K; STORER B; SMALLEY RV; BORDEN EC; WITT P; BROWN R; DATTA S, 1988, 'EFFECT OF ROUTE ON BIOLOGICAL RESPONSE MODIFICATION BY INTERFERON BETA-SER', in PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, pp. 184 - 184

Ko A; Reni M; Riess H; Pelzer U; O'Reilly EM; Winter J; Oh DY; Li CP; Tortora G; Chang HM; Lopez CD; Tabernero J; Van Cutsem E; Philip P; Goldstein D; Berlin JD; Ferrara S; Li M; Lu B; Romano A; Marks H; Biankin A; Tempero MA, 'APACT: Phase III, Multicenter, International, Open-Label, Randomized Trial of Adjuvant nab-Paclitaxel Plus Gemcitabine (nab-P/G) Versus Gemcitabine (G) for Surgically Resected Pancreatic Adenocarcinoma', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1464 - 1464

Back to profile page